Study on the Mechanism of Action of Bu Yang Huan Wu Decoction Against Ischemic Stroke Based on Network Pharmacology and Molecular Docking Analysis
Abstract
identified via the TCM System Pharmacology Database (TCMSP). IS-related targets were collected from CTD, GeneCards, and DisGeNET
databases, while differentially expressed genes (DEGs) were extracted using the Gene Expression Omnibus (GEO) database. Network interactions were constructed in Cytoscape 3.8.2, and protein-protein interaction (PPI) topologies were analyzed. Gene Ontology (GO) and KEGG
enrichment analyses were performed using the David database, and molecular docking validation was conducted via AutoDock Vina. In total,
478 active compounds and 829 IS-related genes were identified, of which 113 core targets were associated with IS treatment. GO analysis
indicated BYHWD involvement in oxidative stress and immune-inflammatory processes. KEGG results revealed pathways including lipid
metabolism, arteriosclerosis, PI3K-Akt signaling, and ferroptosis as relevant. Molecular docking confirmed robust binding affinities between
core therapeutic genes (FOS and TGFB1) and compounds such as β-sitosterol, stigmasterol, and hederagenin. BYHWD demonstrates therapeutic potential via multi-target, multi-component, and multi-pathway regulation, with significant effects on lipid metabolism, inflammation,
and oxidative damage, particularly through the TGFB1/SMAD2/3 signaling axis and ferroptosis-related processes.
Keywords
Full Text:
PDFReferences
[1] Ma, S.T.; Zhang, N.; Hong, G.; Feng, C.T.; Hong, S.W.; Dai, G.L. Unraveling the Action Mechanism of Buyang Huanwu Tang (BYHWT)
for Cerebral Ischemia by Systematic Pharmacological Methodology. Comb Chem High Throughput Screen 2021, 24, 1114–1125, doi:10.
2174/1386207323666200901100529.
[2] Zhan, M.; Zheng, X.; Gao, J.; Shi, S.; Song, W.; Yao, M.; Sun, L.; Fan, X.; Zhang, Y.; Liu, J. Qilong capsule regulates microglial function and inhibits platelet activation after multiple cerebral infarctions by regulating the P2Y(12)/AC/cAMP signalling pathway. J Ethnopharmacol 2025, 345, 119586, doi:10.1016/j.jep.2025.119586.
[3] Wang, R.J.; Ma, G.C.; Yu, S.; Zhang, M.; Pu, S.B. UPLC-MS based metabonomics revealed the protective effects of Buyang Huanwu
decoction on ischemic stroke rats. Toxicol Res (Camb) 2024, 13, tfae052, doi:10.1093/toxres/tfae052.
[4] Mo, J.; Liao, W.; Du, J.; Huang, X.; Li, Y.; Su, A.; Zhong, L.; Gong, M.; Wang, P.; Liu, Z.; et al. Buyang huanwu decoction improves
synaptic plasticity of ischemic stroke by regulating the cAMP/PKA/CREB pathway. J Ethnopharmacol 2024, 335, 118636, doi:10.1016/
j.jep.2024.118636.
[5] Qin, Y.; Hu, S.; Mawen, S.; Pan, S.; Huai, Y.; Liang, G.; Chen, T.; Zhao, F.; Dong, H.; Yao, X.; et al. Neuroprotective mechanisms of
Buyang Huanwu decoction in ischemic stroke. Front Pharmacol 2025, 16, 1620533, doi:10.3389/fphar.2025.1620533.
DOI: http://dx.doi.org/10.70711/pmr.v3i9.9894
Refbacks
- There are currently no refbacks.
